← Back to Search

Stress Inoculation Training for Stress

N/A
Waitlist Available
Led By Nathan J Lewis, MD
Research Sponsored by Virginia Commonwealth University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to up to 3 weeks
Awards & highlights

Study Summary

This trial will test how well medical students learn in high-fidelity simulations of medical settings.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to up to 3 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to up to 3 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in anxiety - visual analog
Change in state-trait anxiety

Side effects data

From 2012 Phase 3 trial • 6104 Patients • NCT01346592
27%
Injection site pain
25%
Pyrexia
14%
Decreased appetite
14%
Upper respiratory tract infection
14%
Diarrhea
10%
Injection site erythema
9%
Nasopharyngitis
9%
Irritability postvaccinal
9%
Headache
8%
Vomiting
8%
Injection site induration
7%
Myalgia
7%
Hypersomnia
7%
Injection site swelling
7%
Fatigue
6%
Crying
6%
Injection site hemorrhage
4%
Gastroenteritis
1%
Pneumonia
1%
Animal Bite
100%
80%
60%
40%
20%
0%
Study treatment Arm
ATIV (6 to <72 Months)
TIV (6 to <72 Months)
Comparator TIV (6 to <72 Months)

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Stress management and hands-on trainingExperimental Treatment2 Interventions
an initial brief lecture with both stress management lecture and additional hands-on training
Group II: Stress managementExperimental Treatment1 Intervention
an initial brief lecture with stress management lecture
Group III: Hands-on trainingActive Control1 Intervention
an initial brief lecture with addition hands-on training for the task
Group IV: LectureActive Control1 Intervention
an initial brief lecture with no further training

Find a Location

Who is running the clinical trial?

Virginia Commonwealth UniversityLead Sponsor
699 Previous Clinical Trials
22,885,033 Total Patients Enrolled
Nathan J Lewis, MDPrincipal InvestigatorVirginia Commonwealth University

Media Library

SIT Clinical Trial Eligibility Overview. Trial Name: NCT04199221 — N/A
Stress Research Study Groups: Stress management and hands-on training, Hands-on training, Lecture, Stress management
Stress Clinical Trial 2023: SIT Highlights & Side Effects. Trial Name: NCT04199221 — N/A
SIT 2023 Treatment Timeline for Medical Study. Trial Name: NCT04199221 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could additional participants join the experiment at this time?

"Clinicaltrials.gov reports that this clinical trial, which was initially published on August 26th 2021 and last updated November 16th 2022, is not presently recruiting participants. However, there are 143 other active studies accepting volunteers right now."

Answered by AI
~3 spots leftby Apr 2025